The hard part about vaccinating against Malaria isn’t the vaccine platform — it’s finding an antigen to target that has the desired effect. But there is progress on that front:

https://blogs.sciencemag.org/pipeline/archives/2021/03/01/a-...

The candidate does indeed use mRNA, but it seems like it could have used older technology too.